Powered by RND

My Life On GLP1

Scott Johnson
My Life On GLP1
Latest episode

Available Episodes

5 of 117
  • S13.E8: My Life On GLP1 - Why Am I Always Cold? (Finally Explained + Real Fixes)
    Wearing fleece in 70-degree weather? You're not alone. Discover why semaglutide and tirzepatide cause "Ozempic chill"—from brown adipose tissue changes to metabolic slowdown. Learn 2025 research on hypothalamic signaling plus practical fixes: layering strategies, heated gear, nutrition tips. Essential for Wegovy, Mounjaro, Zepbound users battling constant coldness. #SideEffects #Ozempic #WeightLoss #Health #GLP1 https://mylifeonglp1.com/  
    --------  
    8:57
  • S13.E7: My Life On GLP1 - Muscle Loss: Sarcopenia Risk & Proven Fixes
    25-40% of weight lost on semaglutide and tirzepatide comes from muscle, not fat. Learn about sarcopenia, DXA scan data revealing lean mass loss, and 5 essential strategies: protein targets, resistance training schedules, and dose titration. Protect your strength while losing weight. Critical listening for anyone over 50 on GLP-1 medications. #Sarcopenia #StrengthTraining #Ozempic #Fitness #GLP1 #muscleloss #mounjaro #zepbound #weightloss https://mylifeonglp1.com/muscle-loss/ https://mylifeonglp1.com/  
    --------  
    7:26
  • S13.E6: My Life On GLP1 - Geographic Use (US, UK, Canada): Where GLP1 Meds Are Exploding
    Why Rhode Island leads 67% growth while Arkansas declines. Map state-by-state, province-by-province GLP-1 adoption patterns across North America and UK. Learn which regions have best access, why postcode lottery affects NHS patients, insurance coverage variations, and coming biosimilar revolution. Essential for understanding regional barriers to Mounjaro, Zepbound availability. #Healthcare #mounjaro #WeightLoss #Canada #GLP1 #UK https://mylifeonglp1.com/  
    --------  
    8:07
  • S13.E5: My Life On GLP1 - Mounjaro & Fatty Liver Disease: Groundbreaking Research
    74% of MASH patients achieved disease resolution with tirzepatide in new trials. We explore how Mounjaro and Zepbound reverse liver scarring, reduce fibrosis, and offer hope for the 30% of Americans with fatty liver disease. From friend Jerry's diagnosis story to clinical trial data, learn why this GLP-1 medication could transform liver treatment forever. #FattyLiver #LiverDisease #Mounjaro #MASH #GLP1 https://mylifeonglp1.com/fatty-liver-disease/ https://mylifeonglp1.com/  
    --------  
    6:39
  • S13.E4: My Life On GLP1 - The Twelve Percent! Real Stats of Side Effects and Usage
    12% of Americans have tried GLP-1 medications—but what are they actually experiencing? We break down the stats: 40% get nausea, 73% have GI issues, why women lose hair 14x more than men, and discontinuation rates by dose. From pharmacy encounters to hospitalization data, get the unfiltered truth about semaglutide and tirzepatide side effects before you start. #Zepbound #SideEffects #WeightLoss #GLP1 #Mounjaro https://mylifeonglp1.com/    
    --------  
    7:12

More Health & Wellness podcasts

About My Life On GLP1

My Life on GLP-1 podcast shares tips, tricks and experiences for those taking a weight loss medication. Visit our website at https://mylifeonglp1.com for more great content!https://mylifeonglp1.com/
Podcast website

Listen to My Life On GLP1, Any Given Runday and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

My Life On GLP1: Podcasts in Family

Social
v7.23.11 | © 2007-2025 radio.de GmbH
Generated: 11/5/2025 - 5:44:31 AM